Skip to main content
HR 3799 111th Congress House Health Administrative law and regulatory procedures Department of Health and Human Services Employee benefits and pensions Government studies and investigations Health care costs and insurance Health care coverage and access Inflation and prices Medicare Prescription drugs

Affordable Access to Prescription Medications Act of 2009

Introduced: October 13, 2009 Introduced by: Johnson, Henry C. "Hank" Democratic · Georgia See on congress.gov
 Everywhere this bill has been 7 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Nov 16, 2009
Referred to the Subcommittee on Health, Employment, Labor, and Pensions.
Oct 14, 2009
Referred to the Subcommittee on Health.
Oct 13, 2009
Referred to House Education and Labor
Oct 13, 2009
Referred to House Ways and Means
Oct 13, 2009
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Labor, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Oct 13, 2009
Referred to House Energy and Commerce
Oct 13, 2009
Introduced in House
 Plain-English summary Congressional Research Service

Affordable Access to Prescription Medications Act of 2009 - Amends title XVIII (Medicare) of the Social Security Act, the Public Health Service Act, the Employee Retirement Income Security Act of 1974 (ERISA), and the Internal Revenue Code, with respect to prescription drug plans, to limit the required co-payment or coinsurance for any one prescription to $200, and for all prescriptions in any month to $500.

Requires the Secretary of Health and Human Services (HHS), for plan years beginning on or after January 1, 2011, to expand the formulary tier exception request process to allow Medicare beneficiaries enrolled in a prescription drug plan to request an exception for a specialty prescription drug as a non-preferred prescription drug.

Requires the Medicare Payment Advisory Commission to study and report to Congress on: (1) the prescription drug program under Medicare part D and the interaction of such program with Medicare beneficiary access to covered drugs under part B; and (2) cost-sharing for prescription drugs under Medicare parts B and D, including an analysis of the impact of eliminating cost-sharing for covered part D drugs for Medicare beneficiaries who incur annual out-of-pocket cost-sharing, after the initial coverage limit, that exceeds 5% of their income and who do not otherwise qualify for an income-related subsidy or other extra help or cost-sharing relief.

What's happening now November 16, 2009

Referred to the Subcommittee on Health, Employment, Labor, and Pensions.

 Committees of jurisdiction 5